Learn More
Medchemexpress LLC Dbco-PEG4-Val-Cit-PAB-MMAF | 2244602-23-9 | 98.7% | 25 MG

Supplier: Medchemexpress LLC HY13099025MG
DBCO-PEG4-Val-Cit-PAB-MMAF is a drug-linker conjugate used in antibody-drug conjugate research. It combines a cleavable PEG-based Val-Cit-PAB linker bearing a DBCO moiety with the tubulin inhibitor MMAF to enable enzyme-triggered payload release and bioorthogonal conjugation via SPAAC.
- Cleavable Val-Cit-PAB linker for cathepsin-mediated payload release.
- DBCO moiety enables SPAAC click chemistry with azide-functionalized partners.
- Contains MMAF tubulin inhibitor as the cytotoxic payload.
- High purity suitable for research use (approximately 98.7%).
- Available in small research pack sizes such as 25 mg.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.